Skip to main content
OpenTrials

Clinical trial condition

C10.114.375.500

Explore clinical trials studying C10.114.375.500. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

C10.114.375.500 trial results

Completed

Impact of the Arrival on the French Market of New First Line Oral Treatments on the Delay Between MS Onset and First Disease Modifying Treatment (DMTs) Administration

NCT03308994

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, C10.114.375.500, +5 more
Locations
  • Groupement des Hôpitaux de l'Institut Catholique de Lille (HICL) Lille, Hauts-de-France, France
  • University Hospital of Lille Lille, Hauts-de-France, France
  • University Hospital Center of Caen Caen, Normandy, France
  • University Hospital of Rouen Rouen, Normandy, France
View Trial Details

Related conditions